Francisco Javier Eizaguirre Arocena-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457

  2. Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease

    Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17

2020

  1. Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 9

  2. Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

    Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515

  3. Predictors of response to exclusive enteral nutrition in newly diagnosed crohn’s disease in children: PRESENCE Study from SEGHNP

    Nutrients, Vol. 12, Núm. 4

  4. Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica

    Frontiers in Pediatrics, Vol. 8

2014

  1. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry

    Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769